What is the correct way to take Obeticholic acid?

Obeticholic acid (Obeticholic acid) is a targeted drug for the treatment of primary biliary cholangitis (PBC). Its dosage and administration method directly affect the efficacy and safety. The generally recommended starting dose is 5 mg once a day for about three months. The relatively low initial dose helps assess patient tolerance and reduces common side effects such as pruritus, mild liver enzyme fluctuations, and elevated blood lipids. Medication should be taken according to the guidance of a doctor, and can be coordinated with routine liver function and bile acid level monitoring to ensure efficacy and safety.

After three months, if the patient's serum alkaline phosphatase (ALP) and/or total bilirubin levels have not reached the ideal range and he tolerates obeticholic acid well, the dose can be increased to a maximum of 10mg once a day to enhance the efficacy of the drug. Long-term follow-up should be paid attention to during medication, including regular examination of liver function, bile acid and lipid indicators, and assessment of the degree of adverse reactions such as itching. For some patients, tolerance can be improved by adjusting the medication time, supplementing it with antipruritic drugs, or taking it in divided doses.

Obeticholic acid should be taken orally as a whole tablet and should not be chewed or crushed to ensure slow release and absorption of the drug. If taken with food, you can choose to take the medicine at a fixed time every day according to your doctor's advice to keep the blood concentration stable. In addition, patients should pay attention to lifestyle management, such as low-fat diet, moderate exercise and regular review while taking the drug, to help the drug maximize its effectiveness.

In short, correct medication method involves not only dose control, but also tolerance monitoring, follow-up management and lifestyle intervention. Through scientific and rational use, obeticholic acid can play a positive role in improving liver function, reducing cholestasis and delaying disease progression in PBC patients, providing a reliable solution for long-term management.

Reference materials:https://en.wikipedia.org/wiki/Obeticholic_acid